Search results for: 'biopharma deaf and alliance of 2004'
- Did you mean
- biopharma deal and alliance of 2016
- Related search terms
- biopharma partnering%3A 2012
- Biopharma Licensing and Collaboration Partners
- biopharma partnering 3a 2021
- biopharma deal and alliances of 2014
- biopharma deaco and alliance of 2017
-
Diagnostic Imaging Collaboration and Licensing Deals 2016-2024November 2024$3,995.00
Diagnostic Imaging Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Global Specialty Pharmaceutical Partnering Terms and Agreements 2019-2024October 2024$3,995.00
Global Specialty Pharmaceutical Partnering Terms and Agreements 2019 to 2024 report provides a detailed understanding and analysis of how and why companies enter specialty pharmaceutical partnering deals.
Learn More -
Autoimmune Collaboration and Licensing Deals 2016-2024October 2024$3,995.00
Autoimmune Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Molecular Diagnostics Collaboration and Licensing Deals 2016-2024November 2024$3,995.00
Molecular Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Precision Medicine Collaboration and Licensing Deals 2019-2024November 2024$3,995.00
Precision Medicine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024
Learn More -
Oncology Collaboration and Licensing Deals 2019-2024October 2024$3,995.00
Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024
Learn More -
Gene Editing Collaboration and Licensing Deals 2016-2024November 2024$3,995.00
Gene Editing Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024August 2024$3,995.00
The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024 report provides comprehensive understanding and unprecedented access to the preclinical stage partnering deals and agreements entered into by the worlds leading healthcare companies
Learn More -
Royalty Rates in Pharmaceutical and Biotechnology DealsSeptember 2024$3,995.00
Essential Benchmark Data for Dealmakers | Global coverage | Updated to 2024 | Over a decade of royalty rates | Deal financials | Contract documents | Royalty rate trends
Learn More -
Licensing Deals in Pharmaceuticals 2019-2024September 2024$3,995.00
Licensing Deals in Pharmaceuticals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2024
Learn More